• SPX
  • 6090.27
  • 0.25 %
  • 15.1602
  • DJI
  • 44642.52
  • -0.28 %
  • -123.1914
  • N225
  • 39091.17
  • -0.77 %
  • -304.4297
  • FTSE
  • 8308.61
  • -0.49 %
  • -40.7695
  • IXIC
  • 19859.773
  • 0.81 %
  • 159.0508
Enochian Biosciences, Inc. (ENOB) Stock Price, News & Analysis

Enochian Biosciences, Inc. (ENOB) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$0.7
Day's range
$0.75
50-day range
$0.3928
Day's range
$2.78
  • Country: US
  • ISIN: US29350E1047
52 wk range
$0.39
Day's range
$2.99
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -8.75
  • Piotroski Score 1.00
  • Grade N/A
  • Symbol (ENOB)
  • Company Enochian Biosciences, Inc.
  • Price $0.71
  • Changes Percentage (1.79%)
  • Change $0.01
  • Day Low $0.70
  • Day High $0.75
  • Year High $2.99

Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-11, a preventative HIV vaccine; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a coopting HBV polymerase. Its pipeline development products comprise ENOB-DC-11 off the shelf DC vaccine for multiple solid tumors; and ENOB-DC-21, a non-specific vaccine for intraturmoral injection. Enochian Biosciences, Inc. has strategic partnerships with The Scripps Institute, Fred Hutchinson Cancer Research Center, the Texas Biomedical Research Institute, the University of California, Los Angeles, and The Hepatitis B Foundation and Baruch S. Blumberg Institute. The company was incorporated in 2017 and is headquartered in Los Angeles, California.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 03/08/2023
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$2.07
  • Trailing P/E Ratio -0.34420289855072
  • Forward P/E Ratio -0.34420289855072
  • P/E Growth -0.34420289855072
  • Net Income $-80,650,171

Income Statement

Quarterly

Annual

Latest News of ENOB

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Enochian Biosciences, Inc. Frequently Asked Questions

  • What is the Enochian Biosciences, Inc. stock price today?

    Today's price of Enochian Biosciences, Inc. is $0.71 — it has increased by +1.79% in the past 24 hours. Watch Enochian Biosciences, Inc. stock price performance more closely on the chart.

  • Does Enochian Biosciences, Inc. release reports?

    Yes, you can track Enochian Biosciences, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Enochian Biosciences, Inc. stock forecast?

    Watch the Enochian Biosciences, Inc. chart and read a more detailed Enochian Biosciences, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Enochian Biosciences, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Enochian Biosciences, Inc. stock ticker.

  • How to buy Enochian Biosciences, Inc. stocks?

    Like other stocks, ENOB shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Enochian Biosciences, Inc.'s EBITDA?

    Enochian Biosciences, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Enochian Biosciences, Inc.’s financial statements.

  • What is the Enochian Biosciences, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0, which equates to approximately 0.00%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Enochian Biosciences, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Enochian Biosciences, Inc.'s financials relevant news, and technical analysis. Enochian Biosciences, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Enochian Biosciences, Inc. stock currently indicates a “sell” signal. For more insights, review Enochian Biosciences, Inc.’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.